Mirum Pharmaceuticals, Inc. Annual Share-based Payment Arrangement, Expense in USD from 2019 to 2023

Taxonomy & unit
us-gaap: USD
Description
Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.
Summary
Mirum Pharmaceuticals, Inc. quarterly/annual Share-based Payment Arrangement, Expense history and growth rate from 2019 to 2023.
  • Mirum Pharmaceuticals, Inc. Share-based Payment Arrangement, Expense for the quarter ending June 30, 2024 was $11.8M, a 41.6% increase year-over-year.
  • Mirum Pharmaceuticals, Inc. Share-based Payment Arrangement, Expense for the twelve months ending June 30, 2024 was $41.4M, a 34.7% increase year-over-year.
  • Mirum Pharmaceuticals, Inc. annual Share-based Payment Arrangement, Expense for 2023 was $35M, a 29.7% increase from 2022.
  • Mirum Pharmaceuticals, Inc. annual Share-based Payment Arrangement, Expense for 2022 was $27M, a 17.3% increase from 2021.
  • Mirum Pharmaceuticals, Inc. annual Share-based Payment Arrangement, Expense for 2021 was $23M, a 83.3% increase from 2020.
Share-based Payment Arrangement, Expense, Trailing 12 Months (USD)
Share-based Payment Arrangement, Expense, Annual (USD)
Share-based Payment Arrangement, Expense, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2023 $35M +$8.02M +29.7% Jan 1, 2023 Dec 31, 2023 10-K 2024-03-15
2022 $27M +$3.99M +17.3% Jan 1, 2022 Dec 31, 2022 10-K 2024-03-15
2021 $23M +$10.5M +83.3% Jan 1, 2021 Dec 31, 2021 10-K 2024-03-15
2020 $12.6M +$6.48M +107% Jan 1, 2020 Dec 31, 2020 10-K 2022-03-09
2019 $6.07M Jan 1, 2019 Dec 31, 2019 10-K 2021-03-09
* An asterisk sign (*) next to the value indicates that the value is likely invalid.